| Debra K Farver, PHARMD | |
|
30948 434th Ave, Yankton, SD 57078-6700 | |
| (605) 668-8306 | |
| Not Available |
| Full Name | Debra K Farver |
|---|---|
| Gender | Female |
| Speciality | Pharmacist - Pharmacotherapy |
| Location | 30948 434th Ave, Yankton, South Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275551467 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P1200X | Pharmacist - Pharmacotherapy | 4334 (South Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Debra K Farver, PHARMD 30948 434th Ave, Yankton, SD 57078-6700 Ph: (605) 668-8306 | Debra K Farver, PHARMD 30948 434th Ave, Yankton, SD 57078-6700 Ph: (605) 668-8306 |
News Archive
New research on innovative immunotherapies for advanced or high-risk melanoma and cervical cancer were presented today at the 50th Annual Meeting of the American Society of Clinical Oncology.
A survey reveals that the need for kidney transplants and dialysis is expected to soar by 2020 mainly due to a rise in diabetics developing chronic kidney disease and needing treatment. The total number of Australians being treated for end-stage kidney disease is forecast to rise by up to 80 per cent to about 4300 in the coming decade. While the fact that Australia's population is ageing and growing means more people are likely to develop end-stage kidney disease, the number of diabetics with the condition is also on the rise.
A team of Vermont investigators has been issued a patent for their discovery of a molecule that rescues damaged blood vessels, yet preserves healthy vessels and could serve as a springboard for a new pharmaceutical therapy with fewer side effects for hypertension - a major risk factor for cardiovascular and kidney disease that effects roughly one in three people in the U.S.
A new study posted to the medRxiv* preprint server explores environmental surveillance of elementary school settings for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) through wastewater and surface samples monitoring. The researchers demonstrated that 93% of the COVID-19 cases in public elementary schools could be identified using this method.
› Verified 6 days ago
Kim Yvette Kortje, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2100 Broadway Ave, Yankton, SD 57078 Phone: 605-665-8261 | |
Mrs. Shona Jussel, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2100 Broadway Ave, Yankton, SD 57078 Phone: 605-665-8261 Fax: 605-665-3371 | |
Dana M List, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2100 Broadway Ave, Yankton, SD 57078 Phone: 605-665-8261 Fax: 605-665-3371 | |
Gloriz Nelson, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2020 Broadway Ave, Yankton, SD 57078 Phone: 605-665-1124 | |
Richard Eugene Erickson Ii, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1100 Douglas Ave, Yankton, SD 57078 Phone: 605-665-3262 Fax: 605-668-1124 | |
Brandon Vincent Kirchner, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2020 Broadway Ave, Yankton, SD 57078 Phone: 605-665-1124 Fax: 605-665-1261 |